SPDR S&P Biotech (XBI) 145.05 $XBI
'Fast Money' Recap: A Game-Changing Twitter Quarter
at The Street - Wed Jul 30, 4:00AM CDT
The trading panel looked at the social media company's earnings, Panera Bread and Spirit Airlines.
Look for Shares of SPDR S&P Biotech ETF to Potentially Pullback after Yesterday's 6.86% Rise
Comtex SmarTrend(R) - Wed Jul 23, 4:35PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $147.64 to a high of $150.99. Yesterday, the shares gained 6.9%, which took the trading range above the 3-day high of $142.31 on volume of 956,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Biotech Stock Mailbag: AcelRx, Yellen Aftermath, Nymox
at The Street - Fri Jul 18, 6:51AM CDT
Biotech columnist Adam Feuerstein answers readers' questions about health care companies.
After Yesterday's Decline of 3.86%, SPDR S&P Biotech ETF Offers Investors Better Value
Comtex SmarTrend(R) - Tue Jul 15, 5:08PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $141.01 to a high of $148.07. Yesterday, the shares fell 3.9%, which took the trading range below the 3-day low of $142.38 on volume of 1.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Fed Chair Yellen Says Small Biotech Stocks Over-Valued
at The Street - Tue Jul 15, 12:10PM CDT
Biotech indices plunge on cautious remarks made by Fed Chairwoman during Congressional testimony.
'Fast Money' Recap: Digging Into Oil Prices
at The Street - Thu Jul 10, 4:00AM CDT
The trading panel looked at whether WTI will go lower, how that will affect transportation stocks and how successful a Kim Kardashian mobile game app can be.
The Zacks Analyst Blog Highlights:iShares Residential Real Estate Capped ETF, First Trust Amex Biotechnology Index Fund, SPDR S&P Biotech ETF, PowerShares Dynamic Semiconductors and SPDR S&P Semiconductor ETF
PR Newswire - Mon Jul 07, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the iShares Residential Real Estate Capped ETF (AMEX:REZ-Free Report), First Trust Amex Biotechnology Index Fund (AMEX:FBT-Free Report), SPDR S&P Biotech ETF (AMEX:XBI-Free Report), PowerShares Dynamic Semiconductors(AMEX
SI-Free Report) and SPDR S&P Semiconductor ETF(AMEX:XSD-Free Report).
3 American ETFs That Saw Fireworks to Start 2014 - ETF News And Commentary
Eric Dutram - ZACKS - Thu Jul 03, 11:00AM CDT
Several US focused ETFs put up gains of at least 20 percent to start 2014.
SPDR S&P Biotech ETF Shares Up 18.9% Since SmarTrend's Buy Recommendation (XBI)
Comtex SmarTrend(R) - Wed Jul 02, 5:10PM CDT
SmarTrend identified an Uptrend for SPDR S&P Biotech ETF (AMEX:XBI) on May 27th, 2014 at $131.80. In approximately 1 month, SPDR S&P Biotech ETF has returned 18.93% as of today's recent price of $156.75.
Vertex Pharma Pushes Biotech ETFs Higher - ETF News And Commentary
Sweta Killa - ZACKS - Wed Jun 25, 1:00PM CDT
The positive trial results of a cystic fibrosis send Vertex Pharmaceuticals and these biotech ETFs higher on Tuesday trading session.
Uptrend Call Working As SPDR S&P Biotech ETF Stock Rises 14.7% (XBI)
Comtex SmarTrend(R) - Wed Jun 25, 11:21AM CDT
SmarTrend identified an Uptrend for SPDR S&P Biotech ETF (AMEX:XBI) on May 27th, 2014 at $131.80. In approximately 4 weeks, SPDR S&P Biotech ETF has returned 14.73% as of today's recent price of $151.21.
How Will Biotechnology ETFs Finish Out the Year? - ETF News And Commentary
Zacks Equity Research - ZACKS - Tue Jun 24, 9:00AM CDT
Which trend will prevail in the volatile biotechnology ETF space.
Shares of XBI Up 15.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Jun 18, 10:04AM CDT
SmarTrend identified an Uptrend for SPDR S&P Biotech ETF (AMEX:XBI) on May 27th, 2014 at $131.80. In approximately 3 weeks, SPDR S&P Biotech ETF has returned 15.14% as of today's recent price of $151.74.
SPDR S&P Biotech ETF Rises 1.87% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Jun 16, 5:51PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $148.71 to a high of $151.27. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $150.77 on volume of 330,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
12.5% Return Seen to Date on SmarTrend SPDR S&P Biotech ETF Call (XBI)
Comtex SmarTrend(R) - Wed Jun 11, 9:32AM CDT
SmarTrend identified an Uptrend for SPDR S&P Biotech ETF (AMEX:XBI) on May 27th, 2014 at $131.80. In approximately 2 weeks, SPDR S&P Biotech ETF has returned 12.48% as of today's recent price of $148.24.
Two Biotech ETFs Surge on Idenix-Merck Deal - ETF News And Commentary
Sweta Killa - ZACKS - Tue Jun 10, 1:00PM CDT
Idenix Pharmaceuticals pushes these two biotech ETFs higher ahead of the rivals on Merck buyout.
'Fast Money' Recap: A Game-Changing Twitter Quarter
at The Street - Wed Jul 30, 4:00AM CDT
The trading panel looked at the social media company's earnings, Panera Bread and Spirit Airlines.
Look for Shares of SPDR S&P Biotech ETF to Potentially Pullback after Yesterday's 6.86% Rise
Comtex SmarTrend(R) - Wed Jul 23, 4:35PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $147.64 to a high of $150.99. Yesterday, the shares gained 6.9%, which took the trading range above the 3-day high of $142.31 on volume of 956,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Biotech Stock Mailbag: AcelRx, Yellen Aftermath, Nymox
at The Street - Fri Jul 18, 6:51AM CDT
Biotech columnist Adam Feuerstein answers readers' questions about health care companies.
After Yesterday's Decline of 3.86%, SPDR S&P Biotech ETF Offers Investors Better Value
Comtex SmarTrend(R) - Tue Jul 15, 5:08PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $141.01 to a high of $148.07. Yesterday, the shares fell 3.9%, which took the trading range below the 3-day low of $142.38 on volume of 1.3 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
Fed Chair Yellen Says Small Biotech Stocks Over-Valued
at The Street - Tue Jul 15, 12:10PM CDT
Biotech indices plunge on cautious remarks made by Fed Chairwoman during Congressional testimony.
'Fast Money' Recap: Digging Into Oil Prices
at The Street - Thu Jul 10, 4:00AM CDT
The trading panel looked at whether WTI will go lower, how that will affect transportation stocks and how successful a Kim Kardashian mobile game app can be.
The Zacks Analyst Blog Highlights:iShares Residential Real Estate Capped ETF, First Trust Amex Biotechnology Index Fund, SPDR S&P Biotech ETF, PowerShares Dynamic Semiconductors and SPDR S&P Semiconductor ETF
PR Newswire - Mon Jul 07, 8:30AM CDT
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and events impacting stocks and the financial markets. Stocks recently featured in the blog include the iShares Residential Real Estate Capped ETF (AMEX:REZ-Free Report), First Trust Amex Biotechnology Index Fund (AMEX:FBT-Free Report), SPDR S&P Biotech ETF (AMEX:XBI-Free Report), PowerShares Dynamic Semiconductors(AMEX
SI-Free Report) and SPDR S&P Semiconductor ETF(AMEX:XSD-Free Report). 3 American ETFs That Saw Fireworks to Start 2014 - ETF News And Commentary
Eric Dutram - ZACKS - Thu Jul 03, 11:00AM CDT
Several US focused ETFs put up gains of at least 20 percent to start 2014.
SPDR S&P Biotech ETF Shares Up 18.9% Since SmarTrend's Buy Recommendation (XBI)
Comtex SmarTrend(R) - Wed Jul 02, 5:10PM CDT
SmarTrend identified an Uptrend for SPDR S&P Biotech ETF (AMEX:XBI) on May 27th, 2014 at $131.80. In approximately 1 month, SPDR S&P Biotech ETF has returned 18.93% as of today's recent price of $156.75.
Vertex Pharma Pushes Biotech ETFs Higher - ETF News And Commentary
Sweta Killa - ZACKS - Wed Jun 25, 1:00PM CDT
The positive trial results of a cystic fibrosis send Vertex Pharmaceuticals and these biotech ETFs higher on Tuesday trading session.
Uptrend Call Working As SPDR S&P Biotech ETF Stock Rises 14.7% (XBI)
Comtex SmarTrend(R) - Wed Jun 25, 11:21AM CDT
SmarTrend identified an Uptrend for SPDR S&P Biotech ETF (AMEX:XBI) on May 27th, 2014 at $131.80. In approximately 4 weeks, SPDR S&P Biotech ETF has returned 14.73% as of today's recent price of $151.21.
How Will Biotechnology ETFs Finish Out the Year? - ETF News And Commentary
Zacks Equity Research - ZACKS - Tue Jun 24, 9:00AM CDT
Which trend will prevail in the volatile biotechnology ETF space.
Shares of XBI Up 15.1% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Jun 18, 10:04AM CDT
SmarTrend identified an Uptrend for SPDR S&P Biotech ETF (AMEX:XBI) on May 27th, 2014 at $131.80. In approximately 3 weeks, SPDR S&P Biotech ETF has returned 15.14% as of today's recent price of $151.74.
SPDR S&P Biotech ETF Rises 1.87% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Jun 16, 5:51PM CDT
SPDR S&P Biotech ETF (AMEX:XBI) traded in a range yesterday that spanned from a low of $148.71 to a high of $151.27. Yesterday, the shares gained 1.9%, which took the trading range above the 3-day high of $150.77 on volume of 330,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
12.5% Return Seen to Date on SmarTrend SPDR S&P Biotech ETF Call (XBI)
Comtex SmarTrend(R) - Wed Jun 11, 9:32AM CDT
SmarTrend identified an Uptrend for SPDR S&P Biotech ETF (AMEX:XBI) on May 27th, 2014 at $131.80. In approximately 2 weeks, SPDR S&P Biotech ETF has returned 12.48% as of today's recent price of $148.24.
Two Biotech ETFs Surge on Idenix-Merck Deal - ETF News And Commentary
Sweta Killa - ZACKS - Tue Jun 10, 1:00PM CDT
Idenix Pharmaceuticals pushes these two biotech ETFs higher ahead of the rivals on Merck buyout.
